BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12495296)

  • 1. Prenatal HIV counseling, testing, and antiretroviral prophylaxis by obstetric and family medicine providers in Alabama.
    Nichols SA; Bhatta MP; Lewis J; Vermund SH
    Am J Med Sci; 2002 Dec; 324(6):305-9. PubMed ID: 12495296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The maternal and child health sites' practices regarding HIV education, counseling, and testing of women of reproductive age in Chicago: barriers to universal implementation.
    Rahimian A; Driscoll M; Taylor D
    Matern Child Health J; 1998 Mar; 2(1):35-44. PubMed ID: 10728257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensuring a public health impact of programs to reduce HIV transmission from mothers to infants: the place of voluntary counseling and testing.
    Bassett MT
    Am J Public Health; 2002 Mar; 92(3):347-51. PubMed ID: 11867305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do North Carolina prenatal care providers counsel and test pregnant women for HIV? Survey measures knowledge of HIV testing benefits.
    Walter EB; Lampe MA; Livingston E; Royce RA
    N C Med J; 1998; 59(2):105-9. PubMed ID: 9558898
    [No Abstract]   [Full Text] [Related]  

  • 6. Human immunodeficiency virus counseling and testing practices among North Carolina providers.
    Troccoli K; Pollard H; McMahon M; Foust E; Erickson K; Schulkin J
    Obstet Gynecol; 2002 Sep; 100(3):420-7. PubMed ID: 12220759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing perinatal HIV transmission: zidovudine use during pregnancy.
    Carmichael C
    Am Fam Physician; 1997 Jan; 55(1):171-4, 177-8. PubMed ID: 9012276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National program for preventing mother-child HIV transmission in Thailand: successful implementation and lessons learned.
    Kanshana S; Simonds RJ
    AIDS; 2002 May; 16(7):953-9. PubMed ID: 11953461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the risk of perinatal HIV-1 transmission with zidovudine: results and implications of AIDS Clinical Trials Group protocol 076.
    Mofenson LM
    Acta Paediatr Suppl; 1997 Jun; 421():89-96. PubMed ID: 9240866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
    Thaineua V; Sirinirund P; Tanbanjong A; Lallemant M; Soucat A; Lamboray JL
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):429-42. PubMed ID: 10437936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal HIV testing and antiretroviral prophylaxis at an urban hospital--Atlanta, Georgia, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jan; 52(51-52):1245-8. PubMed ID: 14704648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decision analysis of mandatory compared with voluntary HIV testing in pregnant women.
    Nakchbandi IA; Longenecker JC; Ricksecker MA; Latta RA; Healton C; Smith DG
    Ann Intern Med; 1998 May; 128(9):760-7. PubMed ID: 9556471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving universal HIV screening in prenatal care in the United States: provider persistence pays off.
    Anderson JE; Koenig LJ; Lampe MA; Wright R; Leiss J; Saul J
    AIDS Patient Care STDS; 2005 Apr; 19(4):247-52. PubMed ID: 15857196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with routine voluntary perinatal human immunodeficiency virus testing in an inner city hospital.
    Henderson SL; Lindsay MK; Higgins JE; Clark WS; Bulterys M; Nesheim SR
    Pediatr Infect Dis J; 2001 Nov; 20(11):1090-2. PubMed ID: 11734720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of mother-to-child transmission of HIV in Thailand: physicians' attitudes on zidovudine use, pregnancy termination, and willingness to provide care.
    Stringer JS; Stringer EM; Phanuphak P; Jetwana P; Reinprayoon D; Funkhouser EM; Vermund SH
    J Acquir Immune Defic Syndr; 1999 Jul; 21(3):217-22. PubMed ID: 10421245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IOM: Make prenatal HIV testing part of routine care. Institute of Medicine.
    AIDS Alert; 1998 Dec; 13(12):137-8. PubMed ID: 11366060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada.
    Samson L; King S
    CMAJ; 1998 Jun; 158(11):1449-57. PubMed ID: 9629106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New report calls for universal testing of pregnant women. Institute of Medicine.
    WORLD; 1998 Nov; (No 91):2-3. PubMed ID: 11365971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.